IVUS- guided PCI Reduces One-Year Target Vessel Failure vs Angiography -guided PCI in Complex Bifurcation PCI: DKCRUSH VIII Trial

By

March 31, 2026

IVUS-guided PCI was Not Associated with Lower Risk of Target-Vessel Failure vs Angiography-guided PCI alone in Complex High-Risk PCI: IVUS-CHIP Trial

By

March 31, 2026

Oral NLRP3 Inhibitor, Parunoflast, Reduces Inflammation Alone and in Combination with Semaglutide in Phase 2a Trial

By

Jessie Fox, PharmD

March 31, 2026

LX2006 Gene Therapy Shows Early Signals of Cardiac Benefit in Friedreich Ataxia Cardiomyopathy

By

Hassan Adam Alhassan MD

March 31, 2026

Tirzepatide Lowers MACE vs Dulaglutide in SURPASS-CVOT Patients With Heart Failure

November 12, 2025

Invasive Coronary Function Testing Identifies High Prevalence of Vasomotor Disorders and Drives Diagnostic Reclassification

March 29, 2026

DR10624, a First-in-Class FGF21/GLUCAGON/GLP-1 Receptor Triple Agonist, Significantly REDUCED Triglycerides, Lipids, and Liver Fat in Patients with Severe HYPERTRIGLYCERIDEMIA

January 24, 2026

Intensive Triglyceride Lowering with Olezarsen Does Not Reduce Coronary Plaque Progression in the Essence-TIMI 73b CCTA Sub Study

March 31, 2026

OCEAN: Ongoing Anticoagulation May Not be Necessary After 1-year Post Successful AF Ablation

January 28, 2026

Interviews

This Week in Medicine: Coronavirus Update with Physicians Throughout the US – Part 4

By

Cardiology Now Media

May 6, 2020

This Week in Medicine: Coronavirus Update with Physicians Throughout the US – Part 3

By

Cardiology Now Media

May 6, 2020

This Week in Medicine: Coronavirus Update with Physicians Throughout the US – Part 2

By

Cardiology Now Media

May 6, 2020